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1. Introduction 
The hormonal form of vitamin D la,25(OH),D,, is 
produced from cholecalciferol (vitamin D3) by C-25 
hydroxylation in the liver, followed by C-l hydroxyl- 
ation in the kidney. The important finding that this 
hormone is synthesized only in the kidney [ 11, and 
the demonstration that patients with advanced renal 
disease are unable to produce la,25(OHhD,, 
prompted the synthesis of its analogues. The most 
widely-used analogue in the treatment of vitamin D 
resistant metabolic bone diseases is la(OH)D, [2-41. 
The beneficial therapeutic effect of this analogue was 
shown to be due to its rapid conversion into 
la,25(OH),D, [S-7]. Thus, patients treated with 
la(OH)D3 are in fact being treated with a potent 
calcium mobilizing agent. and the question has arisen 
therefore whether biological protective mechanisms 
are operating in order to eliminate toxic responses to 
such treatments. 
Previous studies from our laboratories have shown 
that treatment with loc(OH)D, in chicks results in 
high accumulation of a non-polar metabolite(s) in the 
liver [7]. This study describes the characterization of 
these non-polar metabolites, and the possible role 
that these metabolites play in the deactivation of 
la(OH)D3 is discussed. 
Abbreviations: lo1,25(OH),D,, lol,25-dihydroxycholecalciferol; 
la(OH)D,, la-hydroxycholecalciferol; lo1,24,25(OH),D,, 
lq24,25-trihydroxycholecalciferol; ~~I[OH-~-~H]D,, 
lol-[hydroxy-7-3H]cholecalciferol 
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2. Experimental 
2 ,I . AGmals 
Male chicks (light cross; 1 day old) were fed for 
3 weeks on a semi-synthetic vitamin D-free diet [8] 
based on soya-bean meal and glucose. At the end of 
week 3, a group of 5 vitamin D-deficient chicks 
received each a daily subcutanous injection of 0.15 pg 
lol[UH-7-‘H] D3 for 16 days. At the end of this period 
the animals were killed, their livers were removed and 
extracted for lipids. 
2.2. Lipid extraction arzd chromatography 
The livers were weighed, minced and extracted for 
lipids with chloroform/methanol (2: 1, v/v) [9]. The 
non-polar peak was separated by column chromatog- 
raphy with the aid of Sephadex LH-20 (Pharmacia 
Fine Chemicals, Uppsala). The lipids were dissolved in 
chloroform/light petroleum (b.p. 40-~60”C)/methanol 
(75:23:2. by vol.) and applied to a glass column 
(1 X 65 cm) containing Sephadex LH-20 slurried and 
developed in the same solvent. Some 50 fractions 
(3.5 ml) were collected. Aliquots from each fraction 
were counted for radioactivity. Before each run the 
columns were calibrated with authentic metabolites. 
The isolated non-polar peak was further frac- 
tionated into two fractions, I and II (scheme 1) by 
column chromatography with the aid of silica-gel. 
Fraction I was eluted with 40 ml 5% (v/v) diethyl- 
ether in pentane, and fraction II was eluted with 
additional 40 ml 30% (v/v) diethyl-ether in pentane 
(1 X 10 cm columns). Repeated chromatographies 
were performed using either one of the two proce- 
dures described above. 
High pressure liquid chromatography was per- 
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formed on a Model 6000A solvent delivery system 
(Waters Associates, Milford, MA) fitted with 
Lichrosorb SllOO column and using a 2-propanol: 
hexane ( 1:9, v/v) solvent system at a pressure of 
400 p.s.i. 
Fractions to be hydrolysed were dissolved in 155 
(w/v) KOH in methanol, and were left to stand at 
room temperature for 3 days. At the end of this 
period, the mixture was diluted with water, and 
extracted with ethyl acetate and the organic fraction 
was washed several times with water and dried over 
MgSO,. The solvent was evaporated, and the residue 
was subjected to column cl~roIiiatography on Sephadcx 
LH-90 as above. 
2.4. Pwiodate cleavage 
The material was dissolved in 0.3 ml methanol. 
and treated with 0.1 ml 5Tf (w/v) aqueous NaIOJ 
for 16 h at room temperature. The mixture was then 
extracted with ethyl acetate and water, washed twice 
with water and dried over MgSOd. The residue left 
after the solvent was evaporated was subjected to 
column c~lromatography on Sephadex Lii-i-20 as above. 
lo!(OH)D3 and la:[OH-7-3H]D3 with spec. radioact. 
2 Ci/mmol were synthesized in our laboratories as in 
[4,71. 
All radioactivity measurements were carried out in 
a Packard Tri-Carb automatic liquid-scintillation 
spectrometer no. 3390. Lipid samples were counted 
for t.a~~i~~activity m a solution of 100 mg I .4-bis- 
(S-phenyloxal.ole-1-yl) benzene and 4 mg ?,5-diphenyl- 
oxazole/l toluene. Quenching was corrected for by 
using the automatic external standardization and 
correlation curve for 3H. 
3. Results 
Figure 1 demonstrates the elution profile from 
Sephadex LH-20 of lipid extract prepared from chick 
livers after long-term injections of la[U1Y-7-~H]it~. 
The elution profite of radioactivity is composed of 
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25‘- 
Fraction No. ( 3.5 ml) 
1‘1p. 1. Scphaclex LH-20 chromatographic profile of hpid 
extract from chicklivcrsaftcrinJectionswith la[OH-7-‘HID,. 
For experimental details set section 2.2. Peaks: 1. non-polar, 
2, Icu(OH)D la,25(OH),D,.4, la,24,ZS(OH),D,: 
F. 28.0 ml. 
4 peaks. out of which peak 1. the non-polar peak, is 
the major one (6376). Peaks 2, 3 and 4 co-chromato- 
graphed with la(OH)DJ, la,35(OH),D3 and 
lcu.24,35(OH),D3, respectively. 
When peak 1 was subjected to silica-gel column 
chromatography, two fractions were separated 
(I and II, scheme 1). Hydrolysis of fraction I followed 
by column cltr~~~~latography on Sephadex LH-70 gave 
7 fractions (la, lb. scheme 1 f. Fraction Ia was eluted 
with void volume. When cl~ron~atographed on silica-gel 
following additional hydrolysis and separation on 
Sephadex LH-20 it was found to be more polar than 
the original fraction I (Ia’ ). Fraction Ib co-chromato- 
graphed with an authentic sample of la,24( R).3S(OH),DX 
on Sephadex LH-10. On Lreatment with NalOJ this 
material was cleaved. and resulted in the formation of a 
less polar material (Ib’). This indicates that fraction Ib 
consist of lo(,24,2S(OH),D, which upon treatment 
with NaIO, is cleaved to give a non-polar product 
which lost vicinal hydroxyl groups. 
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Scheme I
Fractionation procedure of the non-polar material extracted 
from livers of chicks that were dosed with ta[O?&7-3H]D, 
IIydrolysis of fraction II,-fo~owed by column 
chromatography on Sephadex LH-20 gave 2 fractions 
as well (Ha and Ilb, scheme 1). Fraction IIa was 
eluted with the void volume and fraction IIb upon 
continuous elution. The later fraction was identified 
as la(OH)D, since it co-chromatographed with an 
authentic sample of la(OH)D3 on Sephadex LH-20 
and on high-pressure liquid chromatography. Addi- 
tional hydrolysis of fraction IIa did not alter its 
chromatographic properties on either Sephadex LH-20 
or silica-gel @a’). 
The distribution of the non-polar metabolites of 
Ia(O in chick liver is summarized in table 1. 
4. Discussion 
From the present data it is apparent that long-term 
administration of la(OH)Ds results in the accumula- 
tion of non-polar metabolites in the liver. Since 
hydrolysis of these non-polar substances resulted in 
Table 1 
The distribution of the non-polar metabolites of 
lo(OH)D, in chick liver 
- 
Fraction Metabolite Cont. 
(pmol/g) 
I 
II 
Unidentified 0.30 
101,24,25(OH),D,-ester 0.34 
Unidentified 0.25 
lcu(OH)D,ester 0.18 
more polar metabolites, it is reasonable to assume that 
these are fatty acids esters, as it is known that liver 
contains high concentrations of fatty acids esters of 
vitamin D [ 10,I I]. We suggest hat the less polar ester 
fraction consists of ftiy esterified metabolites and 
the more polar fraction of partially esterified metabo- 
lites. We have identified part of the less polar ester 
fraction as esters of lc~,24,25(OH)~D~. This finding 
explains why only a negligible amount of free 
lc~,24,2S(OH)$~ was detected in tissues of chicks 
that were treated continuously with loc(OH)D3, 
despite the demonstration that kidney homogenates 
derived from vitamin D-fed chicks convert 
lff,2S(OH)*D~ into 1~,24,25(OH)~~ [12]. It seems 
that excess la,25(OH),D3 which is present in normo- 
calcemic animals is being 24-hydroxylated and 
immediately thereafter, esterified. Part of the more 
polar ester fraction was identified as esters of 
la(OH)D3. It appears that only one of the two 
hydroxyl groups in 1&(OH)D3 is esterified, since this 
material has similar polarity on silica-gel as chole- 
calciferol which possess only one hydroxyl group. It 
is possible that excess ltr(OH)D, which is not being 
converted into lo(,25(OH)zD3 is mono-esterified so 
that its conversion to the active la,25(OH),D3 by 
the liver 25hydroxylase is prevented, The two uniden- 
tified metabolites in the non-polar fraction extracted 
from liver deserves further study. Possibly these are 
new compounds, or perhaps substances which were 
formed during fractionation. 
In summary, the present study demonstrates the 
existence of two esterification mechanisms for the 
biological deactivation of la(OH)Ds. The first one is 
operating at the pre-activation stage by the liver 
25hydroxylase, and the second mechanism operates 
when normocalcemia is reached due to the action of 
la,25(OH) in its target cells. Excess lcQS(OM),D, is 
deactivated by 24-hydroxylation followed by esterifi- 
cation of the resulting 1~~,24,35(OH)~Ds. 
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